InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+9.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Groves Regina e, Director. Insider active across 2 companies, notably AtriCure, Inc.. In total, 12 disclosures have been published. Split: 1 buy · 3 sells. Total volume traded: €527k. Activity tracked since 20 May 2021. The latest transaction was filed on 6 August 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Groves Regina e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
2,452 shares@ US$36.8214.7% of flowCommon StockSEC:0001653877-25-000004:0
5,401 shares0Common StockSEC:0001323885-25-000058:0
8,982 shares0Common StockSEC:0000950170-25-074601:0
4,000 shares0Common StockSEC:0000950170-24-062570:0
7,788 shares0Common StockSEC:0001323885-24-000081:0
3,186 shares0Common StockSEC:0001323885-23-000057:0
4,000 shares0Common StockSEC:0001209191-23-000986:0
3,564 shares0Common StockSEC:0001323885-22-000075:0
34 shares@ US$76.680.4% of flowCommon StockSEC:0001209191-21-062074:0
Canonical exit: 29 Jul 2021 (T+90)
3,156 shares@ US$74.7337.8% of flowCommon StockSEC:0001209191-21-056653:0
4,208 shares@ US$71.9547.1% of flowCommon StockSEC:0001209191-21-036518:0
1,749 shares0Common StockSEC:0001209191-21-035348:0
12 of 12 declarations
About Groves Regina e
Regina E Groves is Administrateur and has 12 filings in total. In the recent filings available, the activity concerns AtriCure, Inc. and Fulgent Genetics, Inc., with 2,150 EUR of purchases and 525,261 EUR of sales between 2021-05-24 and 2025-08-08. The most frequent transaction nature is Attribution.
